Vice President, Global Head Pharmaceutical Sciences, Interventional Oncology at Johnson and Johnson @ (September 2018 - September 2023)
Venture Leader, COPD and Lung Cancer, Disease Interception Accelerator @ (January 2016 - September 2018)
Head of Respiratory Discovery, Senior Scientific Director @ (July 2015 - January 2016)
Honorary Professor in Chronic Obstructive Pulmonary Disease @ (February 2012 - January 2017)
Head of Biology, Senior Scientific Director @ Respivert, Ltd. (March 2014 - January 2016)
Christopher Stevenson Education
UC Santa Barbara
PhD (Pharmacology)
1997-2002
Christopher Stevenson Skills
Animal Models
Asthma
Biology
Biomarkers
COPD
Clinical Development
Drug Development
Drug Discovery
In Vitro
In Vivo
Inflammation
Pharmacology
Physiology
Respiratory Disease
Strategic Leadership
Translational Medicine
Translational Research
Western Blotting
Lung
Vendor Management
Strategic Sourcing
Contract Negotiation
Procurement
Strategy
Cross Functional Team Leadership
Global Sourcing
Risk Management
Sourcing
Management
Negotiation
Supply Management
Program Management
Software Licensing
Process Improvement
Business Process Improvement
Outsourcing
CRM
Change Management
Intellectual Property
Portfolio Management
Professional Services
IT Management
Contract Negotiations
Compliance
Risk Mitigation
Contract Management
Christopher Stevenson Summary
Christopher Stevenson, based in London, GB, is currently a Chief Scientific Officer at Engitix Therapeutics. Christopher Stevenson brings experience from previous roles at Johnson & Johnson, The Janssen Pharmaceutical Companies of Johnson & Johnson and University of Southern Denmark. Christopher Stevenson holds a 1997 - 2002 PhD in Pharmacology @ UC Santa Barbara. With a robust skill set that includes Animal Models, Asthma, Biology, Biomarkers, COPD and more. Christopher Stevenson has 4 emails and 6 mobile phone numbers on RocketReach.
Looking for a different Christopher Stevenson?
Find contact details for 700 million professionals.